Serum Levels of Infliximab and Anti-Infliximab Antibodies in Brazilian Patients with Crohn’s Disease

OBJECTIVES: The aim of this study was to evaluate the quantitative serum level of infliximab (IFX) as well as the detection of anti-infliximab antibodies (ATIs) in patients with Crohn’s disease (CD). METHOD: Forty patients with CD under treatment at a tertiary center in southeastern Brazil were eva...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Luis Eduardo Miani Gomes, Francesca Aparecida Ramos da Silva, Lívia Bitencourt Pascoal, Renato Lazarin Ricci, Guilherme Nogueira, Michel Gardere Camargo, Maria de Lourdes Setsuko Ayrizono, João José Fagundes, Raquel Franco Leal
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Elsevier España 2019-04-01
Sarja:	Clinics
Aiheet:	Crohn’s Disease Infliximab Antibody Drug Monitoring
Linkit:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322019000100216&lng=en&tlng=en
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!